Firstly, it was reported to be approximately 20‐fold up‐regulation in pediatric ALL cases resistance to vincristine and daunorubicin,30 and was also distinguished expressed in TEL/AML1 ALL subgroups, this will lead to good outcomes. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.